Keyphrases
Adjuvant Therapy
100%
Interferon-α (IFN-α)
100%
Stage II-III
100%
Malignant Melanoma
100%
Melanoma
66%
High Risk
33%
Tumor Necrosis Factor-α
33%
Lack of Efficacy
33%
Phase II Trial
33%
Survival Benefit
33%
Treatment Duration
33%
Disease-free Survival
33%
Melanoma Patients
33%
Large Trials
33%
Neoadjuvant Setting
33%
Interferon Treatment
33%
Stage IV Melanoma
33%
Adjuvant Trials
33%
Trial Experience
33%
Interferon Therapy
33%
Pleiotropic Cytokine
33%
Medicine and Dentistry
Critical Appraisal
100%
Adjuvant Therapy
100%
Melanoma
100%
Interferon
83%
Tumor Necrosis Factor
16%
Systematic Review
16%
Cytokine
16%
Treatment Duration
16%
Disease Free Survival
16%
Nursing and Health Professions
Melanoma
100%
Adjuvant Therapy
100%
Critical Appraisal
100%
Interferon
83%
Systematic Review
16%
Treatment Duration
16%
Disease Free Survival
16%
Tumor Necrosis Factor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Interferon
83%
Cytokine
16%
Tumor Necrosis Factor
16%
Disease Free Survival
16%
Immunology and Microbiology
interferon
100%
Tumor Necrosis Factor
20%
Cytokine
20%
Disease Free Survival
20%